(19)
(11) EP 3 899 995 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
01.01.2025 Bulletin 2025/01

(45) Mention of the grant of the patent:
04.09.2024 Bulletin 2024/36

(21) Application number: 19898270.4

(22) Date of filing: 20.12.2019
(51) International Patent Classification (IPC): 
H01G 9/00(2006.01)
A61L 31/14(2006.01)
 H01G 9/20(2006.01)
A61L 31/16(2006.01)
(52) Cooperative Patent Classification (CPC):
B33Y 80/00; B33Y 70/10; B33Y 50/00; B33Y 10/00; A61M 37/0069; A61K 9/0024; A61K 47/34; A61L 31/146; A61L 31/16; A61L 31/148; A61L 2300/416; A61L 2300/402; A61L 2300/41; A61L 2300/406; A61L 2300/202
(86) International application number:
PCT/US2019/068056
(87) International publication number:
WO 2020/132569 (25.06.2020 Gazette 2020/26)

(54)

DRUG-ELUTING SURGICAL ARTICLES AND RELATED METHODS

MEDIKAMENTENBESCHICHTETE CHIRURGISCHE ARTIKEL UND VERWANDTE VERFAHREN

ARTICLES CHIRURGICAUX À ÉLUTION DE MÉDICAMENTS ET PROCÉDÉS ASSOCIÉS

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 21.12.2018 US 201862783430 P

(43) Date of publication of application:
27.10.2021 Bulletin 2021/43

(73) Proprietor: Biosapien Inc.
Dan Diego, CA92121 (US)

(72) Inventor:
  • ALI, Khatija Pinky
    Brooklyn, New York 11206 (US)

(74) Representative: Avidity IP 
Broers Building Hauser Forum 21 JJ Thomson Avenue
Cambridge CB3 0FA
Cambridge CB3 0FA (GB)


(56) References cited: : 
CN-A- 102 319 230
US-A1- 2005 112 397
US-A1- 2011 158 963
US-A1- 2014 324 187
 US-A- 3 948 254
US-A1- 2009 264 491
US-A1- 2014 249 643
US-A1- 2016 098 495
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).